Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,033
Total Claims
$715K
Drug Cost
975
Beneficiaries
$734
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+103%
Opioid rate vs peers
70.6% vs 34.8% avg
+74%
Cost per patient vs peers
$734 vs $422 avg
+107%
Brand preference vs peers
9.8% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
70.6%
Opioid Rate
4,968
Opioid Claims
$431K
Opioid Cost
20.5%
Long-Acting Rate
This provider's opioid prescribing rate of 70.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 687 claims · $474K
Generic: 6,346 claims · $241K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 119 | $90K |
| Oxycodone Myristate | 107 | $73K |
| Buprenorphine | 203 | $60K |
| Methylnaltrexone Bromide | 22 | $55K |
| Oxycodone Hcl | 67 | $43K |
| Naloxegol Oxalate | 85 | $40K |
| Oxycodone Hcl/Acetaminophen | 1,241 | $35K |
| Hydrocodone/Acetaminophen | 1,568 | $34K |
| Tapentadol Hcl | 41 | $34K |
| Buprenorphine | 23 | $18K |
| Baclofen | 14 | $18K |
| Milnacipran Hcl | 16 | $16K |
| Pregabalin | 302 | $15K |
| Gabapentin Enacarbil | 19 | $14K |
| Diflorasone Diacetate | 14 | $14K |
Prescribing Profile
48
Unique Drugs
26.0
Anomaly Score
Patient Profile
68
Avg Age
65%
Female
2.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About